Showing results (1-10 of 31) with videos related to
Sort By:
Pageof 4
Biochimica Et Biophysica Acta|September 28, 1998
Investigating the biological functions of DNA topoisomerases in eukaryotic cellsJ L NitissCancer Chemotherapy and Pharmacology|January 1, 1994
Using yeast to study resistance to topoisomerase II-targeting drugsJ L NitissMolecular Pharmacology|November 1, 1996
Mechanisms of cell killing by drugs that trap covalent complexes between DNA topoisomerases and DNAJ L Nitiss, J C WangCancer Research|October 23, 1997
Aclacinomycin A stabilizes topoisomerase I covalent complexesJ L Nitiss, P Pourquier, Y PommierThe Journal of Biological Chemistry|March 14, 2000
A mutation in yeast topoisomerase II that confers hypersensitivity to multiple classes of topoisomerase II poisonsJ Dong, J Walker, J L NitissThe Journal of Biological Chemistry|July 5, 1992
Cytotoxicity of quinolones toward eukaryotic cells. Identification of topoisomerase II as the primary cellular target for the quinolone CP-115,953 in yeastS H Elsea, N Osheroff, J L NitissThe Journal of Biological Chemistry|September 5, 1993
The top2-5 mutant of yeast topoisomerase II encodes an enzyme resistant to etoposide and amsacrineM Jannatipour, Y X Liu, J L NitissCancer Research|January 1, 1993
A temperature sensitive topoisomerase II allele confers temperature dependent drug resistance on amsacrine and etoposide: a genetic system for determining the targets of topoisomerase II inhibitorsJ L Nitiss, Y X Liu, Y HsiungJournal of Natural Products|December 1, 1995
Metabolites of daidzein and genistein and their biological activitiesY C Chang, M G Nair, J L NitissMolecular Pharmacology|October 1, 1994
Mutations in the gyrB domain of eukaryotic topoisomerase II can lead to partially dominant resistance to etoposide and amsacrineJ L Nitiss, P M Vilalta, H Wu, et al.Pageof 4